share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：擬議出售證券
美股SEC公告 ·  2024/11/05 05:44

牛牛AI助理已提取核心訊息

Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 13,871 shares of common stock on November 4, 2024. The shares, valued at an aggregate market value of $120,459, were acquired by Watanabe on November 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no other securities were sold by Watanabe in the past three months, as per the provided transaction history.
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 13,871 shares of common stock on November 4, 2024. The shares, valued at an aggregate market value of $120,459, were acquired by Watanabe on November 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no other securities were sold by Watanabe in the past three months, as per the provided transaction history.
arcutis biotherapeutics的高管Todd Franklin Watanabe計劃在2024年11月4日賣出13,871股普通股。這些股票的總市值爲120,459美元，是Watanabe於2024年11月1日通過arcutis biotherapeutics的限制性股票授予獲得的。根據提供的交易歷史記錄，這筆交易發生在Watanabe在過去三個月內未出售其他證券的時期後。
arcutis biotherapeutics的高管Todd Franklin Watanabe計劃在2024年11月4日賣出13,871股普通股。這些股票的總市值爲120,459美元，是Watanabe於2024年11月1日通過arcutis biotherapeutics的限制性股票授予獲得的。根據提供的交易歷史記錄，這筆交易發生在Watanabe在過去三個月內未出售其他證券的時期後。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間